Organism: Homo sapiens
Gene: 38760_f_at
Selected probe(set): 209846_s_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38760_f_at (209846_s_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-4.5263844
Number of Samples:2 / 5

Experimental	necrotizing myopathy study 2
	Quadriceps femoris biopsy muscle samples from patients with clinical diagnosis of necrotizing myopathy (NM).
Control	inclusion body myositis study 2
	Quadriceps femoris biopsy muscle samples from patients with clinical diagnosis of inclusion body myositis (IBM).

Relative Expression (log2-ratio):4.2314596
Number of Samples:3 / 3

Experimental	glioma study 17 (glioblastoma; A2B5+)
	Oligodendrocyte progenitor cells (OPC) isolated from high grade glioblastoma (grade IV). OPC were isolated using magnetic-activated cell sorting (MACS) with antibodies against A2B5 antigen. Patients were 66 ± 5 years old males.
Control	non-tumor oligodendrocyte progenitor cell sample (cortex)
	Oligodendrocyte progenitor cells (OPC) isolated from cortical tissue, which was obtained from patients with epilepsy, but without any manifested brain cancer. OPC were isolated using magnetic-activated cell sorting (MACS) with antibodies against A2B5 antigen.

Relative Expression (log2-ratio):4.058275
Number of Samples:5 / 2

Experimental	inclusion body myositis study 2
	Quadriceps femoris biopsy muscle samples from patients with clinical diagnosis of inclusion body myositis (IBM).
Control	normal quadriceps tissue
	Quadriceps femoris biopsy muscle samples from control subjects.

Relative Expression (log2-ratio):3.995615
Number of Samples:2 / 3

Experimental	glioma study 17 (anaplastic astrocytoma; A2B5+)
	Oligodendrocyte progenitor cells (OPC) isolated from high grade anaplastic astrocytoma (grade III). OPC were isolated using magnetic-activated cell sorting (MACS) with antibodies against A2B5 antigen. Patients were 45 ± 18 years old.
Control	non-tumor oligodendrocyte progenitor cell sample (cortex)
	Oligodendrocyte progenitor cells (OPC) isolated from cortical tissue, which was obtained from patients with epilepsy, but without any manifested brain cancer. OPC were isolated using magnetic-activated cell sorting (MACS) with antibodies against A2B5 antigen.

Relative Expression (log2-ratio):3.5839443
Number of Samples:3 / 3

Experimental	IL-1b; IFN-g study 1 (84hrs)
	Pancreatic islets isolated by collagenase digestion from brain-dead organ donors and cultured 3-5 days in RPMI 1640 medium containing 5.6 mM glucose, 10% FCS and 2 mM L-glutamine. Thereafter, islets were cultured in presence of human recombinant IL-1b (25 units/ml) and IFN-g (1,000 units/ml) for 84 hours. Media were changed after 2 days.
Control	untreated pancreatic islet sample (84hrs)
	Untreated pancreatic islets isolated by collagenase digestion from brain-dead organ donors and cultured 3-5 days in RPMI 1640 medium containing 5.6 mM glucose, 10% FCS and 2 mM L-glutamine. Thereafter, islets were cultured in fresh media and harvested after 84 hours. Media were changed after 2 days.

Relative Expression (log2-ratio):3.512189
Number of Samples:2 / 2

Experimental	IL-1b; IFN-g study 1 (132hrs)
	Pancreatic islets isolated by collagenase digestion from brain-dead organ donors and cultured 3-5 days in RPMI 1640 medium containing 5.6 mM glucose, 10% FCS and 2 mM L-glutamine. Thereafter, islets were cultured in presence of human recombinant IL-1b (25 units/ml) and IFN-g (1,000 units/ml) for 132 hours. Media were changed after 2 and 5 days.
Control	untreated pancreatic islet sample (132hrs)
	Untreated pancreatic islets isolated by collagenase digestion from brain-dead organ donors and cultured 3-5 days in RPMI 1640 medium containing 5.6 mM glucose, 10% FCS and 2 mM L-glutamine. Thereafter, islets were cultured in fresh media and harvested after 132 hours. Media were changed after 2 and 5 days.

Relative Expression (log2-ratio):3.500061
Number of Samples:2 / 4

Experimental	glioma study 17 (glioblastoma; unsorted)
	Brain cells isolated from high grade glioblastoma (grade IV). Tumor tissue was dissociated using enzymatic treatment and all cells were used for RNA isolation.
Control	non-tumor cortical tissue
	Cortical tissue obtained from patients with epilepsy, but without any manifested brain cancer. The tissue was dissociated using enzymatic treatment, but all brain cell types were used for analyses.

Relative Expression (log2-ratio):3.3751068
Number of Samples:6 / 3

Experimental	TNF-ɑ; TGF-ß2 study 1 (late)
	ARPE-19 retina pigment epithelial cell samples treated with TNF-ɑ (10 ng/ml) and TGF-ß2 (5 ng/ml). Samples were taken 42 and 60 hours after treatment.
Control	untreated ARPE-19 cell sample
	Untreated ARPE-19 retina pigment epithelial cell samples harvested before adding TNF-ɑ (10 ng/ml) and TGF-ß2 (5 ng/ml).

Relative Expression (log2-ratio):3.318142
Number of Samples:2 / 2

Experimental	expO breast cancer study 1 (medullary carcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the breast of patients with medullary carcinoma (NOS).
Control	expO breast cancer study 1 (inflammatory carcinoma; primary)
	Primary tumor tissue samples obtained from the breast of patients with inflammatory carcinoma.

Relative Expression (log2-ratio):3.3152332
Number of Samples:19 / 17

Experimental	rhegmatogenous retinal detachment study 1
	Retina tissue samples from patients with retinal detachment obtained by vitrectomy.
Control	normal retina tissue
	Postmortem retina tissue samples from healthy patients without any diseases of the eye.